Gary Brittenham
Credentials: · ·
History
Pediatrics
Research
Iron-chelating therapy and the treatment of thalassemia
Review · Blood · 1997 · 777 citations
New England Journal of Medicine · 1994 · First of 9 authors · 658 citations
Hepatic iron concentration and total body iron stores in thalassemia major
New England Journal of Medicine · 2000 · 500 citations

34 papers
- BL
16 papers
- SS
15 papers

12 papers · 1 as a fellow

11 papers

8 papers · 2 as a fellow
- BB
7 papers

7 papers
Grants
- 2018–2025
Prebiotic GOS and Lactoferrin for Beneficial Gut Microbiota with Iron Supplements
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $2.6M · Columbia University Health Sciences
- 2019–2025
QSM to Guide Iron Chelating Therapy in Transfusional Iron Overload
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $3.2M · Weill Medical Coll of Cornell Univ
- 2019–2024
Daily Vitamin D for Sickle-Cell Respiratory Complications: Phase 2: IND107584 - 11/14/17
Food and Drug Administration · R01
Contact PI · $1.5M · Columbia University Health Sciences
- 2011–2016
Ph 2 Study of Vitamin D for Tx of Respiratory Complications in Sickle Cell Ds
Food and Drug Administration · R01
Contact PI · $1.6M · Columbia University Health Sciences
Clinical trials
- 2020–2023
Prebiotic GOS and Lactoferrin With Iron Supplements
Principal investigator · Completed
Columbia University
- 2019–2025
Quantitative Susceptibility Mapping (QSM) to Guide Iron Chelating Therapy
Principal investigator · Completed
Weill Medical College of Cornell University
- 2011–2015
Vitamin D for Sickle-cell Respiratory Complications
Principal investigator · Completed · Phase 2
Gary M Brittenham, MD
- 2011–2016
High-Tc Susceptometer to Monitor Transfusional Iron Overload
Principal investigator · Completed
Columbia University


